SAFE Act

Summary

Save Americans from the Fentanyl Emergency Act or the SAFE Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 26 January 2023

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 26 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 26 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 1 February 2023

   Introduced

   Sponsor introductory remarks on measure. (CR H588)

   Source: IntroReferral

5. 3 February 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 26 January 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 26 January 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 26 January 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 26 January 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Pappas, Chris [D-NH-1] · D · Sponsor
• Rep. Newhouse, Dan [R-WA-4] · R · Sponsor
• Rep. Gonzales, Tony [R-TX-23] · R · Sponsor
• Rep. Salazar, Maria Elvira [R-FL-27] · R · Sponsor
• Rep. Craig, Angie [D-MN-2] · D · Cosponsor
• Rep. Davids, Sharice [D-KS-3] · D · Cosponsor
• Rep. Perez, Marie Gluesenkamp [D-WA-3] · D · Cosponsor
• Rep. Spanberger, Abigail Davis [D-VA-7] · D · Cosponsor
• Rep. Kildee, Daniel T. [D-MI-5] · D · Cosponsor
• Rep. Harder, Josh [D-CA-9] · D · Cosponsor
• Rep. Bera, Ami [D-CA-6] · D · Cosponsor
• Rep. Levin, Mike [D-CA-49] · D · Cosponsor
• Rep. Budzinski, Nikki [D-IL-13] · D · Cosponsor
• Rep. Kilmer, Derek [D-WA-6] · D · Cosponsor
• Rep. McCollum, Betty [D-MN-4] · D · Cosponsor
• Rep. Crow, Jason [D-CO-6] · D · Cosponsor
• Rep. Davis, Donald G. [D-NC-1] · D · Cosponsor
• Rep. McClellan, Jennifer L. [D-VA-4] · D · Cosponsor
• Rep. Magaziner, Seth [D-RI-2] · D · Cosponsor
• Rep. Lawler, Michael [R-NY-17] · R · Cosponsor
• · hsif00 · Standing
• · hsju00 · Standing

Related records

• related to → HALT Fentanyl Act
• related to → HALT Fentanyl Act
• related to ← Stopping Overdoses of Fentanyl Analogues Act
• related to ← CEASE Overdose Act of 2023
• related to ← HALT Fentanyl Act
• related to ← Federal Initiative to Guarantee Health by Targeting Fentanyl Act
• related to ← SAFE Act of 2022